tiprankstipranks
Lyell Immunopharma double downgraded to Underperform at BofA after reorg
PremiumThe FlyLyell Immunopharma double downgraded to Underperform at BofA after reorg
25d ago
Lyell Immunopharma downgraded to Underperform from Buy at BofA
Premium
The Fly
Lyell Immunopharma downgraded to Underperform from Buy at BofA
25d ago
Lyell Immunopharma Acquires ImmPACT Bio to Enhance Pipeline
Premium
Company Announcements
Lyell Immunopharma Acquires ImmPACT Bio to Enhance Pipeline
1M ago
Lyell Immunopharma price target lowered to $6 from $9 at BofA
PremiumThe FlyLyell Immunopharma price target lowered to $6 from $9 at BofA
5M ago
Lyell Immunopharma downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Lyell Immunopharma downgraded to Neutral from Buy at H.C. Wainwright
5M ago
Lyell Immunopharma’s Promising CAR T-Cell Therapy Trial Results
Premium
Company Announcements
Lyell Immunopharma’s Promising CAR T-Cell Therapy Trial Results
5M ago
Lyell Immunopharma announces Orphan Drug Designation for LYL845
PremiumThe FlyLyell Immunopharma announces Orphan Drug Designation for LYL845
1y ago
Lyell Immunopharma price target lowered to $8 from $9 at H.C. Wainwright
Premium
The Fly
Lyell Immunopharma price target lowered to $8 from $9 at H.C. Wainwright
1y ago
Lyell Immunopharma treatment of Stage IIB-IV melanoma granted orphan status
Premium
The Fly
Lyell Immunopharma treatment of Stage IIB-IV melanoma granted orphan status
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100